Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)
Clinical trial NCT05658237 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05658237
- Sponsor
- PharmaBio Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-17
- Primary completion
- 2026-01-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.